ALGORHYTHM HOLDINGS INC (RIME) Fundamental Analysis & Valuation

NASDAQ:RIME • US8293225020

Current stock price

1.06 USD
-0.08 (-7.02%)
At close:
1.05 USD
-0.01 (-0.94%)
After Hours:

This RIME fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. RIME Profitability Analysis

1.1 Basic Checks

  • RIME had negative earnings in the past year.
  • In the past year RIME has reported a negative cash flow from operations.
  • The reported net income has been mixed in the past 5 years: RIME reported negative net income in multiple years.
  • In multiple years RIME reported negative operating cash flow during the last 5 years.
RIME Yearly Net Income VS EBIT VS OCF VS FCFRIME Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M -20M

1.2 Ratios

  • RIME has a Return On Assets of -264.67%. This is amonst the worse of the industry: RIME underperforms 98.33% of its industry peers.
  • With a Return On Equity value of -1935.47%, RIME is not doing good in the industry: 96.67% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -264.67%
ROE -1935.47%
ROIC N/A
ROA(3y)-51.31%
ROA(5y)-31.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RIME Yearly ROA, ROE, ROICRIME Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

1.3 Margins

  • RIME has a worse Gross Margin (18.56%) than 76.67% of its industry peers.
  • In the last couple of years the Gross Margin of RIME has declined.
  • RIME does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.56%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.83%
GM growth 5Y-4.28%
RIME Yearly Profit, Operating, Gross MarginsRIME Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. RIME Health Analysis

2.1 Basic Checks

  • RIME does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • RIME has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, RIME has more shares outstanding
  • The debt/assets ratio for RIME is higher compared to a year ago.
RIME Yearly Shares OutstandingRIME Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
RIME Yearly Total Debt VS Total AssetsRIME Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

  • RIME has an Altman-Z score of -9.32. This is a bad value and indicates that RIME is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -9.32, RIME is doing worse than 95.00% of the companies in the same industry.
  • RIME has a Debt/Equity ratio of 2.86. This is a high value indicating a heavy dependency on external financing.
  • RIME has a Debt to Equity ratio of 2.86. This is amonst the worse of the industry: RIME underperforms 96.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.86
Debt/FCF N/A
Altman-Z -9.32
ROIC/WACCN/A
WACC16.57%
RIME Yearly LT Debt VS Equity VS FCFRIME Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

  • RIME has a Current Ratio of 0.53. This is a bad value and indicates that RIME is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of RIME (0.53) is worse than 98.33% of its industry peers.
  • RIME has a Quick Ratio of 0.53. This is a bad value and indicates that RIME is not financially healthy enough and could expect problems in meeting its short term obligations.
  • RIME has a Quick ratio of 0.53. This is amonst the worse of the industry: RIME underperforms 86.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.53
Quick Ratio 0.53
RIME Yearly Current Assets VS Current LiabilitesRIME Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. RIME Growth Analysis

3.1 Past

  • RIME shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 68.34%, which is quite impressive.
  • The Revenue for RIME has decreased by -44.67% in the past year. This is quite bad
  • Measured over the past years, RIME shows a very negative growth in Revenue. The Revenue has been decreasing by -12.76% on average per year.
EPS 1Y (TTM)68.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-104.38%
Revenue 1Y (TTM)-44.67%
Revenue growth 3Y-19.95%
Revenue growth 5Y-12.76%
Sales Q2Q%-83.58%

3.2 Future

  • The Earnings Per Share is expected to decrease by -47.61% on average over the next years. This is quite bad
  • Based on estimates for the next years, RIME will show a very strong growth in Revenue. The Revenue will grow by 2301.92% on average per year.
EPS Next YN/A
EPS Next 2Y-47.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-86.17%
Revenue Next 2Y2301.92%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
RIME Yearly Revenue VS EstimatesRIME Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5B 10B 15B 20B
RIME Yearly EPS VS EstimatesRIME Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2026 0 2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

0

4. RIME Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for RIME. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RIME Price Earnings VS Forward Price EarningsRIME Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RIME Per share dataRIME EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60 -80 -100

4.3 Compensation for Growth

  • A cheap valuation may be justified as RIME's earnings are expected to decrease with -47.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-47.61%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. RIME Dividend Analysis

5.1 Amount

  • No dividends for RIME!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

RIME Fundamentals: All Metrics, Ratios and Statistics

ALGORHYTHM HOLDINGS INC

NASDAQ:RIME (4/10/2026, 8:00:01 PM)

After market: 1.05 -0.01 (-0.94%)

1.06

-0.08 (-7.02%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)11-28
Earnings (Next)04-14
Inst Owners0.95%
Inst Owner Change0%
Ins Owners2.66%
Ins Owner Change60.13%
Market Cap6.11M
Revenue(TTM)14.46M
Net Income(TTM)-28.70M
Analysts82.86
Price Target5.1 (381.13%)
Short Float %29.01%
Short Ratio0.18
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.42
P/FCF N/A
P/OCF N/A
P/B 4.12
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-110.55
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.65
FCFYN/A
OCF(TTM)-1.55
OCFYN/A
SpS2.51
BVpS0.26
TBVpS-0.66
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -264.67%
ROE -1935.47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.56%
FCFM N/A
ROA(3y)-51.31%
ROA(5y)-31.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.83%
GM growth 5Y-4.28%
F-Score3
Asset Turnover1.33
Health
Industry RankSector Rank
Debt/Equity 2.86
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr -874.6%
Cap/Sales 3.81%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.53
Quick Ratio 0.53
Altman-Z -9.32
F-Score3
WACC16.57%
ROIC/WACCN/A
Cap/Depr(3y)61.29%
Cap/Depr(5y)88.63%
Cap/Sales(3y)0.39%
Cap/Sales(5y)0.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)68.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-104.38%
EPS Next YN/A
EPS Next 2Y-47.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-44.67%
Revenue growth 3Y-19.95%
Revenue growth 5Y-12.76%
Sales Q2Q%-83.58%
Revenue Next Year-86.17%
Revenue Next 2Y2301.92%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y24.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-47620%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-6068.67%
OCF growth 3YN/A
OCF growth 5YN/A

ALGORHYTHM HOLDINGS INC / RIME Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ALGORHYTHM HOLDINGS INC?

ChartMill assigns a fundamental rating of 1 / 10 to RIME.


What is the valuation status for RIME stock?

ChartMill assigns a valuation rating of 0 / 10 to ALGORHYTHM HOLDINGS INC (RIME). This can be considered as Overvalued.


What is the profitability of RIME stock?

ALGORHYTHM HOLDINGS INC (RIME) has a profitability rating of 1 / 10.